Condensed Consolidated Balance Sheet  
(unaudited) Pfizer Inc and Subsidiary Companies

(millions of dollars) June 29, 1997 June 30, 1996
Assets    
Current Assets    
  • Cash and cash equivalents
  • $ 1,514 $   870
  • Short-term investments
  • 723 1,106
  • Accounts receivable, less allowances
  • 2,525 2,133
  • Short-term loans
  • 220 334
  • Inventories
  • 1,664 1,441
  • Prepaid expenses, taxes and other current assets
  • 697 607
    Total current assets 7,343 6,491
  • Long-term loans and investments
  • 1,224 606
  • Property, plant and equipment, less accumulated depreciation
  • 3,943 3,571
  • Intangibles, less accumulated amortization, and other assets
  • 3,222 2,951
    Total assets  $15,732 $13,619
    Liabilities and Shareholders’ Equity    
    Current Liabilities    
  • Short-term borrowings, including current portion of long-term debt
  • $2,978 $2,545
  • Other
  • 3,444 3,303
    Total current liabilities 6,422 5,848
  • Long-term debt
  • 731 583
  • Postretirement benefit obligation other than pension plans
  • 407 428
  • Deferred taxes on income and other non-current liabilities
  • 958 727
  • Minority interests
  • 40 49
  • Shareholders’ equity
  • 7,174 5,984
    Total liabilities and shareholders’ equity $15,732 $13,619
    First Half Stock Prices*    
    Six Months Ended
      June 29, 1997 June 30, 1996
    High $61 9/16 $38 11/16
    Low $40 5/16 $30  1/16
    *As reported in The Wall Street Journal; adjusted to reflect the June 1997 two-for-one stock split in the form of a 100% stock dividend.

    Return to Mid Year Report Main Menu


    Logo Imagemap

    Copyright © 1996, 1997 Pfizer Inc All rights reserved.